Clinical Trials Directory

Trials / Completed

CompletedNCT04037904

Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication

Status
Completed
Phase
Study type
Observational
Enrollment
490 (actual)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We will evaluate the long-term changes of gastric H+, K+-adenosine triphosphatase (H+, K+-ATPase) and Interleukin-1B mRNA expression according to Helicobacter pylori (H.pylori) infection and intestinal metaplasia and investigate the long-term effect of H. pylori eradication

Detailed description

H. pylori suppresses gastric acid secretion by repressing gastric acid pump, H+, K+-ATPase, and stimulating Interleukin-1B. In this study, we will evaluate the expression of H+, K+-ATPase and Interleukin-1B mRNA according to H. pylori infection and intestinal metaplasia in controls and patients with gastric cancer. In addition, we observe the changes of H+, K+-ATPase and Interleukin-1B mRNA expression over 5 years after H. pylori eradication.

Conditions

Timeline

Start date
2006-02-01
Primary completion
2022-01-01
Completion
2022-12-01
First posted
2019-07-30
Last updated
2023-04-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04037904. Inclusion in this directory is not an endorsement.